2023 International Congress Archives - Page 83 of 186

Genome Wide Association Studies using TRACTOR reveals new associated loci with Parkinson Disease in a Latino Cohort

T. Leal, V. Borda, M. Gouveia, M. Inca-Martinez, E. Mason, D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Sarapura-Castro, A. Rivera-Valdivia, A. Medina, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Cleveland, USA)
Genome-wide association identifies novel etiological insights associated with Parkinson’s Disease in African and African admixed populations

M. Rizig, S. Bandres Ciga, M. Makarious, O. Ojo, O. Okunoye, K. Levine, E. Sidransky, N. Tayebi, P. Wild Crea, C. Blauwendraat, H. Houlden, J. Hardy, A. Singleton, N. Okubadejo (London, United Kingdom)
Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism

R. Matmurodov, E. Abduqodirov, R. Juraev, O. Naimov, B. Muminov, K. Khalimova, H. Daminova (Tashkent, Uzbekistan)
Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

A. Wiltshire, A. Mahes, S. Wang, R. Zuzuárregui (San Francisco, USA)
Glucocerebrosidase (GCase) activator, Ambroxol, reduces alpha-synuclein serine-129 phosphorylation and oligomers in mutant LRRK2 R1441G mouse brains

Z. Choi, E. Chang, H. Liu, S. Zhang, Y. Ruan, K. Leung, S. Pang, M. Kung, D. Ramsden, S. Ho, P. Ho (Hong Kong, Hong Kong)
Glunomab: a novel therapeutics for the treatment of Parkinson’s Disease

D. Torrente, E. Su, GP. Schielke, M. Warnock, T. Stevenson, K. Mann, F. Lesept, N. Delétage, M. Blanc, D. Vivien, D. Lawrence (Ann Arbor, USA)
Gluten-free diet in Parkinson’s disease patients – feasibility, safety and preliminary results

H. Brozova, K. Polakova, M. Fialova, T. Gentileova, J. Rusz, D. Funda (Prague, Czech Republic)
Glycated alpha-synuclein and it emerging role in early onset of Parkinson’s disease

S. Chatterjee, H. Thakkar, A. Khairnar, R. Shah (Gandhinagar, India)
Gray matter volume changes in occipital and temporal visual brain region are associated with freezing of gait in Parkinson’s

YX. Li, ZL. Luo, XL. Yang (Kunming, China)
GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase shows evidence of pharmacological efficacy in an animal model of Parkinson’s disease.

B. Calvo-Flores Guzman, N. Perez-Carmona, A. Garcia-Collazo, E. Cubero, X. Barril, M. Bellotto, J. Taylor (Lugano, Switzerland)